NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.5702
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NovaBay Pharmaceuticals Employees
As of December 31, 2024, NovaBay Pharmaceuticals had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 12 or -46.15% compared to the previous year.
Employees
14
Change (1Y)
-12
Growth (1Y)
-46.15%
Revenue / Employee
$698,643
Profits / Employee
-$614,857
Market Cap
3.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
NBY News
- 7 weeks ago - NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire
- 3 months ago - NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Business Wire
- 4 months ago - NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - Business Wire
- 4 months ago - NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - Business Wire
- 5 months ago - NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024 - Business Wire
- 5 months ago - Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand - Business Wire
- 6 months ago - NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results - Business Wire
- 6 months ago - NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price - Business Wire